Nakajima Hiroko | Department Of Cancer Stem Cell Biology Osaka University Graduate School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
A case of arteriosclerosis obliterans treated with skin temperature biofeedback method
A Study on Psychosomatic Medicine applied to Middle-aged and Elderly People from the Viewpoint of Gender Role : From the Statistics of Psychosomatic Outpatient Clinics of the Department of Psychosomatic Medicine and the Department of Gynecology
Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells

もっと見る

スポンサーリンク